stella
beta
Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and Over — Stella
Recruiting
Back to Shingles trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(13 sites)
Australia
Emeritus Research, Botany, New South Wales
Canopy Clinical Northern Beaches, Brookvale, New South Wales
Paratus Clinical Research Central Coast, Kanwal, New South Wales
Sutherland Shire Clinical Research, Miranda, New South Wales
Innovate Clinical Research, Waitara, New South Wales
Show all 13 locations
View full record on ClinicalTrials.gov